Radiosensitization of glioma cells by modulation of Met signalling with the hepatocyte growth factor neutralizing antibody, AMG102.

Journal of Cellular and Molecular Medicine
Ian M BuchananKevin Camphausen

Abstract

The hepatocyte growth factor (HGF)/Met signalling pathway is up-regulated in many cancers, with downstream mediators playing a role in DNA double strand break repair. Previous studies have shown increased radiosensitization of tumours through modulation of Met signalling by genetic methods. We investigated the effects of the anti-HGF monoclonal antibody, AMG102, on the response to ionizing radiation in a model of glioblastoma multiforme in vitro and in vivo. Radiosensitivity was evaluated in vitro in the U-87 MG human glioma cell line. Met activation was measured by Western blot, and the effect on survival following radiation was evaluated by clonogenic assay. Mechanism of cell death was evaluated by apoptosis and mitotic catastrophe assays. DNA damage was quantitated by γH2AX foci and neutral comet assay. Growth kinetics of subcutaneous tumours was used to assess the effects of AMG102 on in vivo tumour radiosensitivity. AMG102 inhibited Met activation after irradiation. An enhancement of radiation cell killing was shown with no toxicity using drug alone. Retention of γH2AX foci at 6 and 24 hrs following the drug/radiation combination indicated an inhibition of DNA repair following radiation, and comet assay confirmed DNA damag...Continue Reading

References

Apr 30, 1991·Biochemical and Biophysical Research Communications·O Higuchi, T Nakamura
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K M WeidnerY Daikuhara
Mar 30, 1994·Biochemical and Biophysical Research Communications·S WatanabeN Sato
Jul 17, 1996·International Journal of Cancer. Journal International Du Cancer·E M RosenI D Goldberg
Apr 16, 1998·The Journal of Biological Chemistry·E P RogakouW M Bonner
Jan 26, 2002·Molecular and Cellular Biology·Bo XuMichael B Kastan
Aug 27, 2002·Radiation Protection Dosimetry·A C MillerW F Blakely
Dec 20, 2003·Nature Reviews. Molecular Cell Biology·Carmen BirchmeierGeorge F Vande Woude
Jul 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Timothy M Pawlik, Khandan Keyomarsi
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Apr 6, 2005·Biochemical and Biophysical Research Communications·Lothar SchweigererMonica Hecht
May 4, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Linda E BrökerGiuseppe Giaccone
Jun 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bachchu LalJohn Laterra
Jul 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Chong-Feng GaoGeorge F Vande Woude
Feb 21, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·K Jin KimJohn Laterra
Jul 22, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gagani AthaudaDonald P Bottaro
Jul 25, 2006·Nature Reviews. Cancer·Carla Boccaccio, Paolo M Comoglio
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Andrew M ScottLloyd J Old
Apr 5, 2007·Nature Protocols·Peggy L Olive, Judit P Banáth
Nov 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·H Toni JunTeresa L Burgess
Jun 17, 2008·The Oncologist·Richard Pazdur
May 31, 2008·Nature Reviews. Drug Discovery·Paolo M ComoglioLivio Trusolino
Jul 18, 2008·Cancer Research·Suganthini S GanapathipillaiYitzhak Zimmer
Nov 14, 2008·Nature Reviews. Cancer·William M BonnerYves Pommier
Mar 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joseph Paul EderPatricia M LoRusso
Dec 24, 2009·Radiation Oncology·James W WelshBaldassarre Stea
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael S GordonLia Gore

❮ Previous
Next ❯

Citations

May 11, 2012·Neuro-oncology·Wei Li, Manuel B Graeber
Mar 23, 2013·Neuro-oncology·Sheng-Hua ChuZhi-Qiang Li
Oct 5, 2011·Journal of Visualized Experiments : JoVE·Jacqueline F DonoghueTerrance G Johns
Jun 25, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anita T TandleKevin Camphausen
Feb 26, 2013·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Cyrus ChargariEric Deutsch
Mar 13, 2014·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Stamatia Pouliliou, Michael I Koukourakis
Mar 10, 2015·The International Journal of Biochemistry & Cell Biology·Astrid A GlückMichaela Medová
May 7, 2015·Pharmacology & Therapeutics·Constantinos Alifieris, Dimitrios T Trafalis
Jul 12, 2017·Cancers·Nichola CruickshanksRoger Abounader
Aug 8, 2012·Nature Reviews. Clinical Oncology·Cyrus Chargari, Eric Deutsch
May 9, 2012·Nature Reviews. Clinical Oncology·Solange Peters, Alex A Adjei
Jun 18, 2017·Molecular Cancer Therapeutics·Céline ClémensonEric Deutsch
Feb 20, 2021·International Journal of Nanomedicine·Liuyun GongSuxia Han
Dec 23, 2020·Journal of the National Cancer Institute·Salma K JabbourMansoor M Ahmed

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
electrophoresis
xenografts
xenograft

Software Mentioned

GraphPad
Prism
Adobe Photoshop CS
CASP
ImageJ

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis